Guggenheim analyst Yatin Suneja upgrades ACADIA Pharmaceuticals (NASDAQ:ACAD) from Neutral to Buy and announces $22 price target.
US Ecology Q2 EPS $(0.11) Down From $(0.08) YoY, Sales $240.80M Beat $239.21M Estimate
US Ecology (NASDAQ:ECOL) reported quarterly losses of $(0.11) per share. This is a 37.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $240.80
